Exploring the Genetics of Neuropathic Pain
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorOslo University Hospital
About this trial
In the present study the investigators will search for new genetic variants relevant for the development of neuropathic pain.
Eligibility criteria
Qualifiers
The patient is between 18 and 70 years old.
The patient has consented.
The patient is referred for evaluation of possible distal symmetric polyneuropathy (DSPN).
The patient has filled out the questionnaires.
Disqualifiers
The patient is too sick to participate (eg. bedridden, fever).
The patient is unable to consent (eg. dementia, speech problems, psychiatric disorder).
Inflammatory acute polyneuropathy.
Trial design
Treatments tested in this trial
- Nerve conduction Studies
Treatment groups
5,000 Participants
are divided into 6 treatment groups6
Treatment groupsSee each treatment group below.
Sponsors and collaborators
Oslo University Hospital
Lead sponsor
Haukeland University Hospital
Collaborator
Helse Stavanger HF
Collaborator
St. Olavs Hospital
Collaborator
University Hospital of North Norway
Collaborator
University of Oxford
Collaborator
Danish Pain Research Center
Collaborator
Oslo Metropolitan University
Collaborator
Source ClinicalTrials.gov